Chemistry, Probes & Molecular Therapy (CPMT)

The Chemistry, Probes and Molecular Therapy (CPMT) research group in the Department of Radiology and Biomedical Imaging at UCSF focuses on the development of new molecular imaging tools. This research group will complement our existing research and infrastructure groups to bring targeted therapies to the clinic, for both for the diagnosis and therapy of human disease.

Clinical, Probes and Molecular TherapyPSMA PET image of a patient with metastatic prostate cancer. Whole body view demonstrating numerous sites of metastatic disease, that would have generally not been visualized by conventional imaging (CT or MRI).
Chemistry, Probes & Molecular Therapy (CPMT)Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)David Wilson, MD, PhD - Director of Chemistry, Probes & Molecular Therapy (CPMT)
Amyloid PET Scan for Alzheimer's Disease AssessmentAmyloid PET scan assessment of those with cognitive impairment
Chemistry, Probes & Molecular Therapy (CPMT)Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)CPMT research
   
Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)
Chemistry, Probes & Molecular Therapy (CPMT)

About Chemistry, Probes & Molecular Therapy (CPMT)

CPMT members

CPMT research labs

CPMT conference schedule

Meetings related to the activities of the Chemistry, Probes and Molecular Therapy (CPMT) group will be held on Tuesday afternoons, at China Basin Landing in room 342, unless otherwise noted. The goal is 4-5PM with the exception of longer faculty meetings. These include:

  1. CPMT faculty meetings. These are held quarterly and include AIT SRG faculty members.
  2. Clinical research in progress (CRIP). These are designed for clinical researchers to discuss projects.
  3. Nuclear imaging research. Postdoctoral fellows in the Wilson, VanBrocklin, Flavell, and Evans labs will be presenting biweekly. Researchers at all levels from Mission Bay groups are invited to join.
  4. Visiting speakers. Invited speakers will present on Tuesday afternoons. We welcome suggestions from all CPMT members.

Sienna Huang will be our contact administrator for the CPMT and related research meetings.

Current Conference Schedule

Resources

NIH study sections:

Who we serve

The CPMT’s research will translate to healthier futures for:

  • Personalized medicine
  • Individual patient care according to unique metabolic, genetic, and biochemical profiles

Conditions we address

The clinical application of our research includes special focus on:

  • Cancer
  • Infection
  • Neurodegenerative disease

Who we partner with

We look forward to building relationships a wide range of partners:

  • Patients and their families
  • Researchers from our own and other institutions
  • Visionaries who seek to serve the populations we do
  • Donors committed to improving the lives of others

Who we are

The CPMT is made up of:

  • Clinical and research faculty
  • Radiochemists, physicists, spectroscopists, and nuclear medicine physicians
  • Postdoctoral fellows
  • Research staff
  • Medical and graduate students

Related Content

Molecular Imaging and Therapeutics (MI&T)